Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Published on 10/22/2020

COVID-19 Genomics and Precision Public Health Weekly Update Content

Pathogen and Human Genomics Studies

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    et al. The New England journal of medicine 2020 Oct (16) 1522-1534
    We conducted a genomewide association study involving 1980 patients with Covid-19 and severe disease (defined as respiratory failure) at seven hospitals in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe. We identified a 3p21.31 gene cluster as a genetic susceptibility locus in patients with Covid-19 with respiratory failure and confirmed a potential involvement of the ABO blood-group system.
  • Individuals with Down syndrome hospitalized with COVID-19 have more severe disease
    L Malle et al, Genetics in Medicine, October 18, 2020
    In this retrospective study of 7246 patients hospitalized with COVID-19, we identified 12 patients with DS. Hospitalized individuals with DS are on average ten years younger than patients without DS. Patients with DS have more severe disease than controls, particularly an increased incidence of sepsis and mechanical ventilation.
  • A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
    L Mutesa et al, Nature, October 21, 2020
    We propose an algorithm for pooling subsamples based on the geometry of a hypercube that, at low prevalence, accurately identifies infected individuals in a small number of tests and rounds of testing. We discuss the optimal group size and explain why largely parallel searches are preferred. We report proof of concept experiments in which a positive subsample was detected even when diluted 100-fold with negative subsamples.

Non-Genomics Precision Health Studies

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    et al. The New England journal of medicine 2020 Oct (16) 1522-1534
    We conducted a genomewide association study involving 1980 patients with Covid-19 and severe disease (defined as respiratory failure) at seven hospitals in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe. We identified a 3p21.31 gene cluster as a genetic susceptibility locus in patients with Covid-19 with respiratory failure and confirmed a potential involvement of the ABO blood-group system.
  • Individuals with Down syndrome hospitalized with COVID-19 have more severe disease
    L Malle et al, Genetics in Medicine, October 18, 2020
    In this retrospective study of 7246 patients hospitalized with COVID-19, we identified 12 patients with DS. Hospitalized individuals with DS are on average ten years younger than patients without DS. Patients with DS have more severe disease than controls, particularly an increased incidence of sepsis and mechanical ventilation.
  • A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
    L Mutesa et al, Nature, October 21, 2020
    We propose an algorithm for pooling subsamples based on the geometry of a hypercube that, at low prevalence, accurately identifies infected individuals in a small number of tests and rounds of testing. We discuss the optimal group size and explain why largely parallel searches are preferred. We report proof of concept experiments in which a positive subsample was detected even when diluted 100-fold with negative subsamples.

News, Reviews and Commentaries

  • Genomewide Association Study of Severe Covid-19 with Respiratory Failure.
    et al. The New England journal of medicine 2020 Oct (16) 1522-1534
    We conducted a genomewide association study involving 1980 patients with Covid-19 and severe disease (defined as respiratory failure) at seven hospitals in the Italian and Spanish epicenters of the SARS-CoV-2 pandemic in Europe. We identified a 3p21.31 gene cluster as a genetic susceptibility locus in patients with Covid-19 with respiratory failure and confirmed a potential involvement of the ABO blood-group system.
  • Individuals with Down syndrome hospitalized with COVID-19 have more severe disease
    L Malle et al, Genetics in Medicine, October 18, 2020
    In this retrospective study of 7246 patients hospitalized with COVID-19, we identified 12 patients with DS. Hospitalized individuals with DS are on average ten years younger than patients without DS. Patients with DS have more severe disease than controls, particularly an increased incidence of sepsis and mechanical ventilation.
  • A pooled testing strategy for identifying SARS-CoV-2 at low prevalence
    L Mutesa et al, Nature, October 21, 2020
    We propose an algorithm for pooling subsamples based on the geometry of a hypercube that, at low prevalence, accurately identifies infected individuals in a small number of tests and rounds of testing. We discuss the optimal group size and explain why largely parallel searches are preferred. We report proof of concept experiments in which a positive subsample was detected even when diluted 100-fold with negative subsamples.
Disclaimer: Articles listed in COVID-19 Genomics and Precision Public Health Weekly Update are selected by Public Health Genomics Branch to provide current awareness of the scientific literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the Clips, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
TOP